Pacira: FDA OKs application for pediatric Exparel

-- EXPAREL is the first and only FDA-approved long-acting local analgesic for children aged six and over –
-- Conference call tomorrow at 8:30 a.m. ET --

The Pacira management team will host a conference call to discuss the contents of this press release Tuesday, March 23rd, at 8:30 a.m. ET. To participate in the conference call, dial 1-877-845-0779 and provide the passcode 1185087. International callers may dial 1-720-545-0035 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com.

For those unable to participate in the live call, a replay will be available at 1-855-859-2056 (domestic) or 1-404-537-3406 (international) using the passcode 1185087. The replay of the call will be available for one week from the date of the live call. The webcast will be available on the Pacira website for approximately two weeks following the call.

https://finance.yahoo.com/news/pacira-announces-fda-approval-supplemental-224200070.html